A carregar...
Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine
SARS‐CoV is a new type of human coronavirus identified as a causative agent of severe acute respiratory syndrome (SARS). On the occasion of the SARS outbreak, various monoclonal antibodies (mAbs) against SARS‐CoV have been developed and applied for diagnosis, clinical management and basic research....
Na minha lista:
| Publicado no: | Rev Med Virol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd.
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7169118/ https://ncbi.nlm.nih.gov/pubmed/16518829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmv.492 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|